Subset of DN Memory B Cells Expressing Low Levels of Inhibitory Receptor BTLA Is Enriched in SLE Patients.

Autor: Aubergeon, Lucie¹ (AUTHOR), Felten, Renaud^1,2 (AUTHOR), Gottenberg, Jacques-Eric^1,2 (AUTHOR), Dumortier, Hélène¹ (AUTHOR), Monneaux, Fanny¹ (AUTHOR) f.monneaux@ibmc-cnrs.unistra.fr

Publikováno v: Cells (2073-4409). Dec2024, Vol. 13 Issue 24, p2063. 16p.

Causal role of the pyrimidine deoxyribonucleoside degradation superpathway mediation in Guillain-Barré Syndrome via the HVEM on CD4 + and CD8 + T cells.

Autor: Liu, Xianghua¹ (AUTHOR), Liu, Lingling² (AUTHOR), Zhang, Jiuchang^1,3 (AUTHOR) zhang9chang@sina.com

Publikováno v: Scientific Reports. 11/9/2024, p1-14. 14p.

Focusing on CD8⁺ T-cell phenotypes: improving solid tumor therapy.

Autor: Yao, Zhouchi¹ (AUTHOR), Zeng, Yayun² (AUTHOR), Liu, Cheng¹ (AUTHOR), Jin, Huimin² (AUTHOR), Wang, Hong³ (AUTHOR), Zhang, Yue² (AUTHOR) 2021000048@usc.edu.cn, Ding, Chengming¹ (AUTHOR) 2018011096@usc.edu.cn, Chen, Guodong¹ (AUTHOR) chenguodong@usc.edu.cn, Wu, Daichao^1,2 (AUTHOR) wudaichao@usc.edu.cn

Publikováno v: Journal of Experimental & Clinical Cancer Research (17569966). 9/28/2024, Vol. 43 Issue 1, p1-30. 30p.

BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1

Autor: Watanabe, N., Gavrieli, M., Sedy, J. R., Yang, J., Fallarino, Francesca, Loftin, S. K., Hurchla, M. A., Zimmerman, N., Sim, J., Zang, X., Murphy, T. L., Russell, J. H., Allison, J. P., Murphy, K. M.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3982::8c066b756bc2d59afe871b60e09609a8
http://hdl.handle.net/11391/154853

BTLA deficiency promotes HSC activation and protects against hepatic ischemia-reperfusion injury.

Autor: Shen X; Key Laboratory of Endoscopic Technology Research, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China., Mai R; Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, P.R. China., Han X; Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, P.R. China., Wang Q; Key Laboratory of Endoscopic Technology Research, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China., Wang Y; Key Laboratory of Endoscopic Technology Research, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China., Ji T; Key Laboratory of Endoscopic Technology Research, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China., Tong Y; Key Laboratory of Endoscopic Technology Research, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China., Chen P; Key Laboratory of Endoscopic Technology Research, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China., Zhao J; Key Laboratory of Endoscopic Technology Research, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China., He X; Key Laboratory of Endoscopic Technology Research, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China., Wen T; Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, P.R. China., Liang R; Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, P.R. China., Lin Y; Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, P.R. China., Luo X; Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, P.R. China., Cai X; Key Laboratory of Endoscopic Technology Research, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China.

Publikováno v: Hepatology communications [Hepatol Commun] 2024 Jun 05; Vol. 8 (6). Date of Electronic Publication: 2024 Jun 05 (Print Publication: 2024).